바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
사전등록 바로가기
 

Tuberculosis & Respiratory Diseases

논문 상세

이전 다음
논문 투고

Vol.73 No.2
Citation Share

Analysis of Patients with Hemoptysis in a Tertiary Referral Hospital

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2012, v.73 no.2, pp.107-114
이보람 (전남대학교)
임성철 (전남대학교)
Jin Yeong Yu (Chonnam National University Medical School)
Hee Jung Ban (Chonnam National University Medical School)
오인재 (전남대학교)
김규식 (전남대학교)
권용수 (전남대학교)
김유일 (전남대학교)
김영철 (전남대학교)
이보람, 임성철, Jin, Y. Y. , Hee, J. B. , 오인재, 김규식, 권용수, 김유일, & 김영철. (2012). . Tuberculosis & Respiratory Diseases, 73(2), 107-114.
  • 다운로드 수
  • 조회수
PDF 다운로드

Abstract

Background: This study attempted to investigate the main causes of hemoptysis, the type of examinations used for diagnosis, the treatment modalities and outcomes. Methods: A retrospective study was conducted on the medical records of 221 patients admitted to the Chonnam National University Hospital, between January 2005 and February 2010, with hemoptysis. Results: Bronchiectasis (32.6%), active pulmonary tuberculosis (18.5%), fungus ball (10.8%), and lung cancer (5.9%) accounted for most causes of hemoptysis. Computed tomography scan was the most sensitive diagnostic test when employed alone, with positive yield of 93.2%. There were 161 cases of conservative treatment (72.9%), 42 cases of bronchial artery embolization (BAE) (19.0%), and 18 cases of surgery (8.1%). Regarding the amount of hemoptysis, 70 cases, out of 221 cases, were mild (31.5%), 36 cases moderate (16.2%), and 115 cases massive hemoptysis (52.0%). Most of the patients were treated conservatively, but if there was more bleeding present,BAE or surgery was more commonly performed than the conservative treatment (p≤0.0001). In the multivariate model, severe hemoptysis and lung cancer were independently associated with short-term recurrence. BAE was independently associated with long-term recurrence, and lung cancer was associated with in-hospital mortality. The overall in-hospital mortality rate was 11.3%. Conclusion: Hemoptysis is a common symptom with a good prognosis in most cases. However, patients exhibiting massive bleeding or those with malignancy had a poorer prognosis. In-hospital mortality was strongly related to the cause, especially in lung cancer.

keywords
Hemoptysis, Etiology, Diagnosis, Therapeutics, Treatment Outcome

참고문헌

1.

1. Kim SK. Differential diagnosis of hemoptysis. Korean J Med 1998;55:634-41.

2.

2. Yoon W, Kim JK, Kim YH, Chung TW, Kang HK. Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics 2002;22:1395-409.

3.

3. Knott-Craig CJ, Oostuizen JG, Rossouw G, Joubert JR, Barnard PM. Management and prognosis of massive hemoptysis: recent experience with 120 patients. J Thorac Cardiovasc Surg 1993;105:394-7.

4.

4. Santiago S, Tobias J, Williams AJ. A reappraisal of the causes of hemoptysis. Arch Intern Med 1991;151:2449- 51.

5.

5. Fernando HC, Stein M, Benfield JR, Link DP. Role of bronchial artery embolization in the management of hemoptysis. Arch Surg 1998;133:862-6.

6.

6. Fidan A, Ozdoğan S, Oruç O, Salepçi B, Ocal Z, Cağlayan B. Hemoptysis: a retrospective analysis of 108 cases. Respir Med 2002;96:677-80.

7.

7. Ayed A. Pulmonary resection for massive hemoptysis of benign etiology. Eur J Cardiothorac Surg 2003;24: 689-93.

8.

8. Crocco JA, Rooney JJ, Fankushen DS, DiBenedetto RJ, Lyons HA. Massive hemoptysis. Arch Intern Med 1968; 121:495-8.

9.

9. Erdogan A, Yegin A, Gürses G, Demircan A. Surgical management of tuberculosis-related hemoptysis. Ann Thorac Surg 2005;79:299-302.

10.

10. McCollun WB, Mattox KL, Guinn GA, Beall AC Jr. Immediate operative treatment for massive hemoptysis. Chest 1975;67:152-5.

11.

11. Kim SO, Oh IJ, Kim KS, Yu YK, Lim SC, Kim YC, et al. Recurrent hemoptysis after bronchial artery embolization. Tuberc Respir Dis 2001;51:364-72.

12.

12. Swanson KL, Johnson CM, Prakash UB, McKusick MA, Andrews JC, Stanson AW. Bronchial artery embolization: experience with 54 patients. Chest 2002;121:789- 95.

13.

13. Chung WY, Byun MK, Park MS, Hahn CH, Kang SM, Lee DY, et al. Risk factors of recurrent hemoptysis after bronchial artery embolization. Tuberc Respir Dis 2006; 60:65-71.

14.

14. Rémy J, Arnaud A, Fardou H, Giraud R, Voisin C. Treatment of hemoptysis by embolization of bronchial arteries. Radiology 1977;122:33-7.

15.

15. Yeo DS, Lee SY, Hyun DS, Lee SH, Kim SC, Choi YM, et al. Effect of bronchial artery embolization (BAE) in management of massive hemoptysis. Tuberc Respir Dis 1999;46:53-64.

16.

16. Abal AT, Nair PC, Cherian J. Haemoptysis: aetiology, evaluation and outcome: a prospective study in a third-world country. Respir Med 2001;95:548-52.

17.

17. Mayr B, Ingrisch H, Häussinger K, Huber RM, Sunder- Plassmann L. Tumors of the bronchi: role of evaluation with CT. Radiology 1989;172:647-52.

18.

18. Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest 1997;112:440-4.

19.

19. Strickland B. Investigating haemoptysis. Br J Hosp Med 1986;35:242, 246-51.

20.

20. Brinson GM, Noone PG, Mauro MA, Knowles MR, Yankaskas JR, Sandhu JS, et al. Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis. Am J Respir Crit Care Med 1998;157(6 Pt 1):1951-8.

21.

21. Mal H, Rullon I, Mellot F, Brugière O, Sleiman C, Menu Y, et al. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest 1999;115:996-1001.

Tuberculosis & Respiratory Diseases

논문 투고 OA 정책